Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14376 - 14400 of 14516 in total
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Esaxerenone is under investigation in clinical trial NCT02722265 (Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension).
Investigational
R-95845 is an inhibitor of HIV-1 reverse transcriptase.
Experimental
Investigational
BMS-488043 has been investigated as an anti-HIV agent.
Investigational
CG0070 is investigated in clinical trials for treating bladder cancer. CG0070 is a solid. CG0070 can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and immune-mediated cell killing stimulated by GM-CSF. CG0070, an oncolytic virus therapy with specificity for multiple cancers, has been evaluated...
Investigational
Matched Description: … can potentially destroy cancer cells by two different mechanisms: direct cell killing by the virus and
BMS-911543 has been used in trials studying the treatment of Cancer.
Investigational
Saroglitazar has been investigated for the treatment of Fatty Liver.
Investigational
Rivoglitazone (INN) is a thiazolidinedione undergoing research for use in the treatment of type 2 diabetes. It is being developed by Daiichi Sankyo Co.
Experimental
Investigational
Displaying drugs 14376 - 14400 of 14516 in total